Ran Zheng
Net worth: - $ as of 2026-08-30
Net worth: - $ as of 2026-08-30
Ran Zheng is currently an Independent Director at Caribou Biosciences, Inc. since 2021.
Former roles include Chief Executive Officer & Director at Landmark Bio PBLLC from 2021 to 2025, Vice President-Development Supply Chain at Amgen, Inc., and Chief Technical Officer at Orchard Therapeutics Plc from 2019 to 2021.
Education includes graduate studies at the University of Minnesota and undergraduate studies at Beijing Forestry University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 0 ( -.--% ) | - $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Director/Board Member | 2021-09-23 |
| Companies | Position | End |
|---|---|---|
Landmark Bio PBLLC
Landmark Bio PBLLC BiotechnologyHealth Technology Manufactures and develops cell & gene therapy products | Chief Executive Officer | 2024-12-31 |
| ORCHARD THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2021-01-31 |
| AMGEN INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing Forestry University
Beijing Forestry University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Landmark Bio PBLLC
Landmark Bio PBLLC BiotechnologyHealth Technology Manufactures and develops cell & gene therapy products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions